270,000+
PORTFOLIO
Busy labs face mounting pressure to accelerate drug discovery, reduce costs, and deliver reproducible results, all while managing increasingly complex cell models. Manual workflows can’t keep pace.
The CellXpress.ai® Automated Cell Culture System is an AI-driven, automated cell culture solution that streamlines workflows, improves assay reliability, and enhances reproducibility while freeing researchers to focus on their science - ultimately accelerating drug discovery and ensuring therapeutics reach the market faster.
It gives your team total control, visibility, and traceability across the entire cell journey while maintaining hands-off 24/7 operations for growing and scaling multiple PDO/iPSC cell lines, spheroids, or organoids.
Scale up with confidence: Expand complex workflows, including brain organoids, with validated, turnkey protocols for feeding, monitoring, and passaging up to 100 plates across multiple cell lines in parallel*. Boost organoid production by up to 25X**, enabling large-scale studies without compromising quality.
Free your team to focus on science: Save approximately 200 hours*** of manual labor per week with autonomous feeding, monitoring, and passaging - even on weekends.
Reduce variability and risk: Standardize workflows and minimize contamination with AI-powered decision-making and image-based monitoring for reproducible results. Get fully traceable, reproducible cell cultures.
Accelerate drug discovery timelines: Reach clinical trials faster and prevent late stage failures with reproducible, traceable and robust culturing of physiologically relevant cell models.
The CellXpress system is an approachable, truly hands-off automated solution built by scientists, for scientists, so you never have to worry about missing a feeding or passaging step. Watch this in-depth demo, presented by Dr. Serena Cervantes, that gives a detailed walkthrough of the system and its software. Then speak with an expert to discuss how your lab can integrate AI-driven, automated 2D and 3D cell culture processes to make disease modeling and drug screening workflows more reliable and reproducible.
Brain organoids: For neuroscience, neurotoxicity, modeling neurodevelopmental and neurodegenerative diseases, and accelerating the discovery of new therapeutics.
Colorectal Cancer Organoids: Biologically relevant CRC PDOs can exhibit drug responses similar to that of patients, pointing to their value in predicting the efficacy of novel therapeutics.
